Jubilant HollisterStier LLC
Jubilant HollisterStier LLC
ALLERGENIC EXTRACTS IN BULK VIALS
FULL PRESCRIBING INFORMATION: CONTENTS*
FULL PRESCRIBING INFORMATION
ANIMAL ALLERGENS, AP HORSE HAIR AND DANDER DESCRIPTION
The allergenic extract in this vial is referred to as a "bulk" extract or stock concentrate since it is designed primarily for the physician equipped to prepare dilutions and mixtures as required. The extract is sterile and intended for subcutaneous injection for immunotherapy and scratch, prick or puncture for diagnosis. Unless specified otherwise, the concentration of extract supplied will in most cases be expressed in weight to volume (e.g., 1:10 or 1:20 w/v) and will be the strongest available. Where mixtures of pollens and non-pollens have been ordered, the mixed extract will be treated as a pollen mixture. To insure maximum potency for the entire dating period, all bulk concentrates will contain 50% volume to volume (v/v) glycerin unless otherwise requested. Dilutions will also be prepared with 50% (v/v) glycerin unless another diluent is specified.
Source materials utilized in allergenic extract products include pollens, molds, animal epidermals, insects, foods and environmental materials.
Pollens are collected using techniques such as waterset or vacuuming, cleaned and purified to greater than 99% single specie pollen (less than 1% foreign particle presence).
Molds are typically grown on synthetic nutrient medias and are derived from the surface growth (mycelia).
Animal source materials are collected from animals deemed to be healthy at the time of collection by a veterinarian or individual trained and certified by a veterinarian. Epidermals include feathers, hair and dander, or the whole epidermal (pelt) as described on product labeling.
Regular process epidermals are extractions of the source material without additional processing, except that certain materials are defatted. AP™ (acetone precipitated) epidermal source materials are derived from the precipitate formed when acetone is added to an aqueous extract. The resulting precipitate is dried, and becomes the source material for the AP™ product.
Insects are collected in whole body form. Extractions take place as whole body or ground insects.
Information on Foods and other Environmental source materials can be obtained by contacting our Customer Service Department.
The following is a brief summary of the six methods of describing allergenic product concentration.
1. Weight to volume (w/v). Weight to volume (w/v) describes the weight of allergenic source material added to a given volume of extracting fluid. A 1:10 w/v extract, e.g., indicates that the solution contains the extractable material from one gram of raw material added to each 10 mL Glycero-Coca's or 10 mL Coca's extracting fluid. The amount and composition of extracted materials will vary with the type of antigen, the extracting fluid, duration of extraction, pH, temperature, and other variables. Pollens are typically extracted at a 1:20 w/v ratio in Glycero-Coca's while Coca's extracts are 1:10 w/v. Epidermal, environmental, regular molds and insect products are typically extracted at 1:10 w/v. AP™ (acetone precipitated) epidermal products are prepared at a 1:50 w/v concentration (i.e., 1 gram of dried precipitate in 50 mL of reconstitution fluid). AP™ Dog Hair-Dander is prepared at 1:100 w/v concentration. (i.e., 1 gram of dried precipitate in 100 mL of reconstitution fluid.)
2. Protein Nitrogen Units per mL (PNU/mL). One protein nitrogen unit represents 0.00001 mg phosphotungstic acid precipitable protein nitrogen dissolved in one mL of antigen extract. The PNU content of extracts of the same antigen may vary according to the method of measuring the PNU. Thus, the PNU content of extracts from different manufacturers is not comparable unless the PNU method is known to be the same and is reproducible from lot to lot. The amount of protein nitrogen extracted from the source material is influenced by such factors as the type of antigen, the extracting fluid, duration of extraction, pH, temperature and other variables. Allergenic materials make up a variable proportion of the total protein of an extract. Most allergenic extracts are assayed for PNU. Specific PNU information is available upon request.
3. Amb a 1. Of the many allergens from Short Ragweed which have been purified and characterized [Amb a 1 3 (also known as Antigen E), Amb a 2 3 (also known as Antigen K), Ra3 4, Ra4 (BPA-R) 5, Ra5 6, Ra6, Ra7, Ra87, and cytochrome C 8], Amb a 1 is considered the most important and has been selected as the basis for standardization. Extracts of Short Ragweed containing Amb a 1 are diffused in agar against standard anti-serum to Amb a 1, and compared to the diffusion of standard Amb a 1 solutions. The amount of Amb a 1 is expressed as units of Amb a 1 per mL of extract. A Short Ragweed pollen extracted at 1:20 (w/v) usually assays within a range of 50,000 to 70,000 PNU/mL and 100 to 300 units of Amb a 1 per mL.
The Amb a 1 concentration of any Short Ragweed extract which is diluted with a diluent or other allergenic extracts is determined by calculation. The resulting Amb a 1 value does not reflect the total potency of the product if Short Ragweed extract is mixed with another allergenic extract.
4. Allergy Units per mL (AU/mL). The potency of extracts labeled in Allergy Units (AU)/mL is determined by in vitro comparison to a reference standard established by the Center for Biologics Evaluation and Research (CBER) of the Food and Drug Administration (FDA).
5. Bioequivalent Allergy Units per mL (BAU/mL). Other standardized allergenic extracts are labeled in Bioequivalent Allergy Units/mL (BAU/mL) based on their comparison (by in vitro assay or major allergen content) to CBER, FDA Reference Preparations. The FDA reference extracts have been assigned Bioequivalent Allergy Units based on the CBER ID50EAL method.9 Briefly, highly sensitive patients are skin tested to the reference preparation using an intradermal technique employing 3-fold extract dilutions. Depending on the dilution which elicits a summation of erythema diameter of 50, Bioequivalent Allergy Units are assigned as follows:
BAU/mL
|
D50 Range
|
100,000
|
13.9 - 15.9
|
10,000
|
10.9 - 12.9
|
1,000
|
8.8 - 10.8
|
100
|
6.7 - 8.7
|
References labeled 10,000 BAU/mL can be diluted one to a half million fold, and references labeled 100,000 BAU/mL can be diluted one to 5 million fold and produce a sum of erythema diameter of 50 mm when Intradermal testing highly reactive subjects.
6. Concentrate. Concentrate label terminology applies to allergenic extract mixtures, where the individual allergens being combined vary in strength or the designation of strength.
e.g. Concentrate
50% Short Ragweed 1:20 w/v
25% Std. Cat Pelt 10,000 BAU/mL
25% Mite D. farinae 10,000 AU/mL
Should the physician choose to calculate the actual strength of each component in the "Concentrate" mixture, the following formulation may be used:
Actual Allergen Strength in Concentrate
|
=
|
Allergen Manufacturing Strength
|
X
|
% Allergen in Formulation (by volume or parts)
|
Ingredients: Active ingredients are the allergen(s) noted on the vial label. Preservative is 50% (v/v) glycerin, or 0.4% phenol, as indicated on the vial label. Additional ingredients are 0.5% sodium chloride, and 0.275% sodium bicarbonate.
CLINICAL PHARMACOLOGY
11, 12, 13, 1410, 15, 16, 17, 18, 19ANIMAL ALLERGENS, AP HORSE HAIR AND DANDER INDICATIONS AND USAGE
20,21,22,23Allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. The selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing.
The use of mixed or unrelated antigens for skin testing is not recommended since, in the case of a positive reaction, it does not indicate which component of the mix is responsible for the reaction, while, in the case of a negative reaction, it fails to indicate whether the individual antigens at full concentration would give a positive reaction. Utilization of such mixes for compounding a treatment may result, in the former case, in administering unnecessary antigens and, in the latter case, in the omission of a needed antigen.
Avoidance of allergens is to be advocated if possible, but cannot always be attained, e.g., allergy to dog dander in kennel owners and employees, dog breeders, research workers, veterinarians, etc.
Allergens to which a patient is extremely sensitive should not be included in treatment mixes with allergens to which there is much less sensitivity, but should be administered separately. This allows individualized and better control of dosage increases, including adjustments in dosage becoming necessary after severe reactions which may occur with the highly reactive allergen.
ANIMAL ALLERGENS, AP HORSE HAIR AND DANDER CONTRAINDICATIONS
PRECAUTIONSWARNINGS12WARNINGS
WARNINGS PRECAUTIONSDOSAGE AND ADMINISTRATIONDOSAGE AND ADMINISTRATIONDOSAGE AND ADMINISTRATIONADVERSE REACTIONSADVERSE REACTIONSPRECAUTIONSADVERSE REACTIONS WARNINGS PRECAUTIONS
1. General
1, 24, 25, 26, 27DOSAGE and ADMINISTRATIONADVERSE REACTIONS WARNINGSADVERSE REACTIONS2. Information for Patients
WARNINGS 3. Drug Interactions
Patients
with cardiovascular diseases and/or pulmonary diseases such as
symptomatic unstable, steroid-dependent asthma, and/or those who are
receiving cardiovascular drugs such as beta blockers, may be at higher
risk for severe adverse reactions. These patients may also be more
refractory to the normal allergy treatment regimen. Patients should be
treated only if the benefit of treatment outweighs the risks.1
Patients
on beta blockers may be more reactive to allergens given for testing or
treatment and may be unresponsive to the usual doses of epinephrine
used to treat allergic reactions.2 (See WARNINGS). Certain medications may lessen the skin test wheal and
erythema responses elicited by allergens and histamine for varying time
periods. Conventional antihistamines should be discontinued at least 5
days before skin testing. Long acting antihistamines should be
discontinued for at least 3 weeks prior to skin testing. 28 Topical steroids should be discontinued at the skin test site for at least 2-3 weeks before skin testing.28, 29
Tricyclic antidepressants such as Doxepin should be withheld for at least 7 days before skin testing. 30 Topical local anesthetics may suppress the flare responses and should be avoided in skin test sites.31
4. Carcinogenesis, Mutagenesis, Impairment of Fertility
Long-term studies in animals have not been conducted with allergenic extracts to determine their potential for carcinogenicity, mutagenicity or impairment of fertility.
5. Pregnancy
WARNINGS PRECAUTIONS 336. Nursing Mothers
There are no current studies on the secretion of allergenic extract components in human milk or their effect on the nursing infant. Because many drugs are excreted in human milk, caution should be exercised when allergenic extracts are administered to a nursing woman.
7. Pediatric Use
34, 358. Geriatric Use
The reactions from immunotherapy can be expected to be the same in elderly patients as in younger ones. Elderly patients may be more likely to be on medication that could block the effect of epinephrine which could be used to treat serious reactions, or they could be more sensitive to the cardiovascular side effect of epinephrine because of pre-existing cardiovascular disease. 36
ANIMAL ALLERGENS, AP HORSE HAIR AND DANDER ADVERSE REACTIONS
Physicians administering allergenic extract testing or treatment materials should be experienced in the treatment of severe systemic reactions. See WARNINGS box at the beginning of this package insert.
1. Local Reactions
Some erythema, swelling or pruritus at the site of injection are common, the extent varying with the patient. Such reactions should not be considered significant unless they persist for at least 24 hours. Local reactions (erythema or swelling) which exceed 4-5 cm in diameter are not only uncomfortable, but also indicate the possibility of a systemic reaction if dosage is increased. In such cases the dosage should be reduced to the last level not causing the reaction and maintained at this level for two or three treatments before cautiously increasing again. Large persistent local reactions may be treated by local cold, wet dressings and/or the use of oral antihistamines. They should be considered a warning of possible severe systemic reactions and an indication of the need for temporarily reduced dosages. A mild burning immediately after the injection is to be expected. This usually subsides in 10 to 20 seconds.
2. Systemic Reactions
With careful attention to dosage and administration, systemic reactions occur infrequently, but it cannot be overemphasized that in sensitive individuals, any injection could result in anaphylactic shock. Therefore, it is imperative that physicians administering allergenic extracts understand and be prepared for the treatment of severe reactions.
Most severe systemic reactions will begin within a 30 minute time period, but systemic reactions may occur at any time after skin tests or immunotherapy. Symptoms may range from mild to life-threatening (due to anaphylaxis)as described below.
Other possible systemic reactions which may occur in varying degrees of severity are laryngeal edema, fainting, pallor, bradycardia, hypotension, angioedema, cough, wheezing, conjunctivitis, rhinitis, and urticaria. Adverse reaction frequency data for allergenic extract administration for testing and treatment show that risk is low. 1, 37
If a systemic or anaphylactic reaction does occur, apply a tourniquet above the site of injection and inject 1:1,000 epinephrine-hydrochloride intramuscularly or subcutaneously into the opposite arm. Loosen the tourniquet at least every 10 minutes. Do not obstruct arterial blood flow with the tourniquet.
EPINEPHRINE DOSAGE:
ADULT: 0.3 to 0.5 mL should be injected. Repeat in 5 to 10 minutes if necessary.
PEDIATRIC: The usual initial dose is 0.01 mg (mL) per kg body weight or 0.3 mg (mL) per square meter of body surface area. Suggested dosage for infants to 2 years of age is 0.05 mL to 0.1 mL; for children 2 to 6 years, 0.15 mL; and children 6 to 12 years, 0.2 mL. Single pediatric doses should not exceed 0.3 mg (mL). Doses may be repeated as frequently as every 20 minutes, depending on the severity of the condition and the response of the patient. After administration of epinephrine, profound shock or vasomotor collapse should be treated with intravenous fluids, and possibly vasoactive drugs. Airway patency should be insured. Oxygen should be given by mask. Intravenous antihistamine, inhaled bronchodilators, theophylline and/or adrenal corticosteroids may be used if necessary after adequate epinephrine and circulatory support has been given. Emergency resuscitation measures and personnel trained in their use must be available immediately in the event of a serious systemic or anaphylactic reaction not responsive to the above measures [Ref. J. Allergy and Clinical Immunology, 77(2):p. 271-273, 1986].
Rarely are all of the above measures necessary; the tourniquet and epinephrine usually produce prompt responses. However, the physician should be prepared in advance for all contingencies. Promptness in beginning emergency treatment measures is of utmost importance.
Severe systemic reactions mandate a decrease of at least 50% in the next dose, followed by cautious increases. Repeated systemic reactions, even of a mild nature, are sufficient reason for the cessation of further attempts to increase the reaction-causing dose.
3.
Adverse Event Reporting
Report all adverse events to Jubilant HollisterStier LLC, Customer Technical Services Department at 1 (800) 992-1120. A voluntary adverse event reporting system for health professionals is available through the FDA MEDWATCH program. Preprinted forms (FDA Form 3500) are available from the FDA by calling 1 (800) FDA-1088. Completed forms should be mailed to MEDWATCH, 5600 Fisher Lane, Rockville, MD 20852-9787 or Fax to: 1 (800) FDA-0178.
OVERDOSE SECTION
See ADVERSE REACTIONS.
DOSAGE AND ADMINISTRATION 1. General
DESCRIPTIONWARNINGS2. Pediatric Use
The dose for the pediatric population is the same as for adults.
3. Geriatric Use
The dose for elderly patients is the same as for adult patients under 65.36
HOW SUPPLIED
In 10 mL, 30 mL and 50 mL vials at the w/v, Concentrate, v/v dilution of Concentrate, AU/mL (Standardized Mite Extracts: D. farinae, D. pteronyssinus 10,000 and 30,000 AU/mL; Mite Mixtures: 5,000 AU/mL each species, or 15,000 AU/mL each species), BAU/mL (Standardized Cat Hair and Cat Pelt extracts: 10,000 BAU/mL; Standardized Grass extracts: 10,000 and 100,000 BAU/mL); Amb a 1 units/mL; or PNU/mL ordered by the physician. Please see the current Allergy Product Catalog.
STORAGE AND HANDLING
The expiration date is listed on the container label. To ensure the maximum potency, the extract and its dilutions should be stored at 2° - 8°C, and kept in this temperature range at all times, even during use. Dilutions are less stable than concentrates. If loss of potency is suspected, dilutions should be checked by skin testing with equal v/v dilutions of a freshly prepared dilution on individuals known to be allergic to the specific allergen.
LIMITED WARRANTY
A number of factors beyond our control could reduce the efficacy of this product or even result in an ill effect following its use. These include storage and handling of the product after it leaves our hands, diagnosis, dosage, method of administration and biological differences in individual patients. Because of these factors, it is important that this product be stored properly and that the directions be followed carefully during use. No warranty, express or implied, including any warranty of merchantability or fitness, is made. Representatives of the Company are not authorized to vary the terms or the contents of any printed labeling, including the package insert, for this product except by printed notice from the Company's headquarters. The prescriber and user of this product must accept the terms hereof.
REFERENCES
50In Vivo
Animal Allergens, AP Horse Hair and Dander
AP Horse Hair and Dander INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-4855 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-4855-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-4855-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-4855-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1978-01-30 |
|
|
Animal Allergens, AP Cattle Hair and Dander
Cattle Hair and Dander INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-4811 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-4811-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-4811-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-4811-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1978-01-30 |
|
|
Animal Allergens, AP Dog Hair and Dander Canis spp
Animal Allergens, Dog Dander Canis spp INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-4824 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-4824-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-4824-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-4824-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1976-08-24 |
|
|
Animal Allergens, Dog Hair and Dander Canis spp.
Dog Hair Canis spp. INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-4083 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-4083-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-4083-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-4083-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Animal Allergens, Dog Hair and Dander Canis spp.
Dog Hair Canis spp. INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-4085 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-4085-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-4085-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-4085-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Animal Allergens, Feather Mix
Feather Mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-4349 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-4349-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-4349-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-4349-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Animal Allergens, Feather Mix
Feather Mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-4352 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-4352-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-4352-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-4352-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Animal Allergens, Guinea Pig Hair and Dander
Guinea Pig Hair and Dander INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-4401 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-4401-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Dust, House Mixture
Dust, House Mixture INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-4700 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
HOUSE DUST HOUSE DUST |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-4700-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-4700-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-4700-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Dust, House Mixture
Dust, House Mixture INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-4703 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
HOUSE DUST HOUSE DUST |
|
20000 [PNU]
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-4703-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-4703-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-4703-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Dust, House Mixture
Dust, House Mixture INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-4704 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
HOUSE DUST HOUSE DUST |
|
10000 [PNU]
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-4704-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-4704-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-4704-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
AP House Dust Mix
AP House Dust Mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-4707 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
HOUSE DUST HOUSE DUST |
|
20000 [PNU]
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-4707-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-4707-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-4707-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1972-08-17 |
|
|
AP House Dust Mix
AP House Dust Mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-4708 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
HOUSE DUST HOUSE DUST |
|
20000 [PNU]
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-4708-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-4708-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-4708-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1972-08-17 |
|
|
Food - Animal Products and Poultry Products, Beef Bovine spp.
Beef Bovine spp. INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3077 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
BEEF Beef |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3077-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Animal Products and Poultry Products, Chicken Meat Gallus sp.
Chicken Meat Gallus sp. INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3173 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
Poultry Poultry |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3173-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Animal Products and Poultry Products, Egg, White Gallus sp.
Egg, White Gallus sp. INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3248 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
EGG WHITE Egg White |
|
0.05 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3248-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Animal Products and Poultry Products, Egg, Yolk Gallus sp.
Egg, Yolk Gallus sp. INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3254 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
EGG YOLK Egg Yolk |
|
0.05 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3254-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Animal Products and Poultry Products, Pork Sus sp.
Pork Sus sp. INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3509 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
PORK Pork |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3509-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Dairy Products, Casein, Cow Milk
Casein, Cow Milk INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3380 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
CASEIN Casein |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3380-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Dairy Products, Milk, Whole Cow
Milk, Whole Cow INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3389 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
COW MILK COW MILK |
|
0.05 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3389-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Fish and Shellfish, Clam
Clam INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3191 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
QUAHOG, UNSPECIFIED Quahog, Unspecified |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3191-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Fish and Shellfish, Codfish Gadus callarias
Codfish Gadus callarias INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3203 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
COD, UNSPECIFIED Cod, Unspecified |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3203-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Fish and Shellfish, Crab Xiphosurus sowerbyi
Crab Xiphosurus sowerbyi INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3215 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
Crab Leg, Unspecified Crab Leg, Unspecified |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3215-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Fish and Shellfish, Lobster Homarus americanus
Lobster Homarus americanus INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3362 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
Lobster, Unspecified Lobster, Unspecified |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3362-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Fish and Shellfish, Salmon Salmo salar
Salmon Salmo salar INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3565 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
SALMON, UNSPECIFIED Salmon, Unspecified |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3565-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Fish and Shellfish, Shrimp Crago sp.
Shrimp Crago sp. INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3584 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
SHRIMP, UNSPECIFIED Shrimp, Unspecified |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3584-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Fish and Shellfish, Tuna Thunnus sp.
Tuna Thunnus sp. INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3674 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
TUNA, UNSPECIFIED Tuna, Unspecified |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3674-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Almond Prunus amygdalus
Almond Prunus amygdalus INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3014 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
ALMOND |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3014-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Apple Malus sp.
Apple Malus sp. INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3020 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
APPLE |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3020-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Banana Musa sapientum
Banana Musa sapientum INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3041 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
BANANA |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3041-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Brazil Nut Bertholletia excelsa
Brazil Nut Bertholletia excelsa INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3107 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
BRAZIL NUT Brazil Nut |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3107-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Carrot Daucus carota
Carrot Daucus carota INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3125 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
CARROT |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3125-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Cashew Nut Anacardium occidentalie
Cashew Nut Anacardium occidentalie INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3134 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
CASHEW Cashew |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3134-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Celery Apium graveolens
Celery Apium graveolens INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3140 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
CELERY Celery |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3140-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Corn Zea mays
Corn Zea mays INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3212 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
CORN |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3212-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Hazelnut (Filbert) Corylus spp.
Hazelnut (Filbert) Corylus spp. INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3305 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
Hazelnut, Unspecified Hazelnut, Unspecified |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3305-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Melon, Cantaloupe Cucumis melo
Cantaloupe Cucumis melo INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3116 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
CANTALOUPE Cantaloupe |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3116-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Orange Citrus sinensis
Orange Citrus sinensis INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3428 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
ORANGE |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3428-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Pea, Green or English Pisum sativum
Pea, Green or English Pisum sativum INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3449 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
PEA |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3449-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Peach Prunus persica
Peach Prunus persica INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3452 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
PEACH Peach |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3452-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Peanut Arachis hypogaea
Peanut Arachis hypogaea INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3455 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
PEANUT Peanut |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3455-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Pecan Carya illinoensis
Pecan Carya illinoensis INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3461 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
PECAN Pecan |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3461-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Potato, White Solanum tuberosum
Potato, White Solanum tuberosum INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3518 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
POTATO Potato |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3518-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Rice, Whole Grain
Rice, Whole Grain INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3548 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
RICE RICE |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3548-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Rye Grain
Rye Grain INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3554 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
RYE |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3554-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Soybean Glycine soja
Soybean Glycine soja INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3596 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
SOYBEAN |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3596-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Strawberry Fragaria chiloensis
Strawberry Fragaria chiloensis INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3626 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
Strawberry |
|
0.05 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3626-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, String Bean Mix
String Bean Mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3074 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
STRING BEAN String Bean |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3074-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Tomato Nicotiana spp.
Tomato Nicotiana spp. INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3656 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
TOMATO |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3656-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Walnut, Black Juglans nigra
Walnut, Black Juglans nigra INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3695 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
BLACK WALNUT Black Walnut |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3695-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Yeast, Baker Saccharomyces cerevisiae
Yeast, Baker Saccharomyces cerevisiae INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3713 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
yeast |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3713-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Food - Plant Source, Yeast, Brewer Saccharomyces cerevisiae
Yeast, Brewer Saccharomyces cerevisiae INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-3716 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
yeast |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-3716-2 |
10 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Insects (whole body) cockroach, American Periplaneta americana
Insects (whole body) cockroach, American Periplaneta americana INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-6580 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
PERIPLANETA AMERICANA PERIPLANETA AMERICANA |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-6580-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-6580-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-6580-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Insects (whole body) Cockroach, German Blatella germanica
Insects (whole body) Cockroach, German Blatella germanica INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-6581 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
BLATELLA GERMANICA BLATELLA GERMANICA |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-6581-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-6581-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-6581-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Insects (whole body) cockroach mix
Insects (whole body) cockroach mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-6584 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-6584-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-6584-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-6584-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Insects (whole body) cockroach mix
Insects (whole body) cockroach mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-6587 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-6587-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-6587-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-6587-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Insects (whole body) cockroach mix
Insects (whole body) cockroach mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-6588 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-6588-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-6588-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-6588-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Insects (whole body) cockroach mix
Insects (whole body) cockroach mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-6589 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-6589-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-6589-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-6589-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Insects (whole body) cockroach mix
Insects (whole body) cockroach mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-6590 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-6590-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-6590-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-6590-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Insects (whole body), Fire Ant Mix
Insects (whole body), Fire Ant Mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-6518 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-6518-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-6518-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-6518-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Insects (whole body), Fire Ant Mix
Insects (whole body), Fire Ant Mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-6517 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-6517-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-6517-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-6517-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds - Alternaria/Hormodendrum Mix
Molds - Alternaria/Hormodendrum Mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5004 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5004-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5004-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5004-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds - Mold Mix 10
Molds - Mold Mix 10 INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5136 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5136-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5136-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5136-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds - Mold Mix 4
Molds - Mold Mix 4 INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5000 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5000-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5000-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5000-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds - Trichophyton Mix
Molds - Trichophyton Mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5284 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5284-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5284-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5284-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Penicillium Mix
Molds, Penicillium Mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5168 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5168-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5168-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5168-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Alternaria tenuis
Alternaria tenuis INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5008 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
ALTERNARIA ALTERNATA ALTERNARIA ALTERNATA |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5008-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5008-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5008-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Aspergillus fumigatus
Aspergillus fumigatus INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5020 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
ASPERGILLUS FUMIGATUS ASPERGILLUS FUMIGATUS |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5020-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5020-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5020-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Aspergillus niger
Aspergillus niger INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5032 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5032-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5032-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5032-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Botrytis cinerea
Botrytis cinerea INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5048 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
BOTRYTIS CINEREA BOTRYTIS CINEREA |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5048-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5048-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5048-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Candida albicans
Candida albicans INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5052 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
CANDIDA ALBICANS candida albicans |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5052-1 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5052-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5052-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Candida albicans
Candida albicans INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5055 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
CANDIDA ALBICANS candida albicans |
|
0.001 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5055-1 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5055-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5055-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Cephalosporium acremonium
Cephalosporium acremonium INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5056 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
ACREMONIUM STRICTUM Acremonium strictum |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5056-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5056-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5056-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Curvularia spicifera
Curvularia spicifera INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5076 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
COCHLIOBOLUS SPICIFER Cochliobolus spicifer |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5076-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5076-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5076-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Epicoccum nigrum
Epicoccum nigrum INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5100 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
EPICOCCUM NIGRUM EPICOCCUM NIGRUM |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5100-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5100-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5100-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Epidermophyton floccosum
Epidermophyton floccosum INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5104 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
EPIDERMOPHYTON FLOCCOSUM Epidermophyton floccosum |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5104-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5104-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5104-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Fusarium vasinfectum
Fusarium vasinfectum INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5112 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5112-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5112-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5112-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Helminthosporium interseminatum
Helminthosporium interseminatum INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5124 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
Dendryphiella vinosa Dendryphiella vinosa |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5124-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5124-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5124-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Hormodendrum cladosporioides
Hormodendrum cladosporioides INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5128 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5128-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5128-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5128-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Mucor racemosus
Mucor racemosus INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5144 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
MUCOR RACEMOSUS mucor racemosus |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5144-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5144-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5144-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Penicillium notatum
Penicillium notatum INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5208 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5208-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5208-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5208-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Phoma herbarum
Phoma herbarum INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5220 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
PHOMA EXIGUA VAR. EXIGUA Phoma exigua var. exigua |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5220-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5220-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5220-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Pullularia pullulans
Pullularia pullulans INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5235 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5235-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5235-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5235-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Rhizopus nigricans
Rhizopus nigricans INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5230 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
RHIZOPUS STOLONIFER RHIZOPUS STOLONIFER |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5230-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5230-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5230-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Molds, Rusts and Smuts, Stemphylium botryosum
Stemphylium botryosum INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-5264 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
PLEOSPORA TARDA PLEOSPORA TARDA |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-5264-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-5264-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-5264-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Grasses, Bahia Grass Paspalum notatum
Bahia Grass Paspalum notatum INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-1081 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
PASPALUM NOTATUM POLLEN PASPALUM NOTATUM POLLEN |
|
0.05 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-1081-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-1081-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-1081-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Grasses, Bahia Grass Paspalum notatum
Bahia Grass Paspalum notatum INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-1084 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
PASPALUM NOTATUM POLLEN PASPALUM NOTATUM POLLEN |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-1084-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-1084-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-1084-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Grasses, Brome, Smooth Bromus inermis
Brome, Smooth Bromus inermis INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-1237 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
BROMUS INERMIS POLLEN BROMUS INERMIS POLLEN |
|
0.05 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-1237-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-1237-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-1237-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Grasses, Corn, Cultivated Zea mays
Corn, Cultivated Zea mays INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-1414 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
ZEA MAYS POLLEN ZEA MAYS POLLEN |
|
0.05 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-1414-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-1414-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-1414-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Grasses, Johnson Grass Sorghum halepense
Johnson Grass Sorghum halepense INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-1744 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
SORGHUM HALEPENSE POLLEN SORGHUM HALEPENSE POLLEN |
|
0.05 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-1744-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-1744-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-1744-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Grasses, Johnson Grass Sorghum halepense
Johnson Grass Sorghum halepense INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-1747 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
SORGHUM HALEPENSE POLLEN SORGHUM HALEPENSE POLLEN |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-1747-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-1747-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-1747-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Grasses, Oats, Common, Cultivated Avena sativa
Oats, Common, Cultivated Avena sativa INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-2041 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
AVENA SATIVA POLLEN AVENA SATIVA POLLEN |
|
0.05 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-2041-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-2041-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-2041-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Grasses, Grass Mix 8
Grass Mix 8 INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-0879 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-0879-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Grasses, Southern Grass Mix
Pollens - Grasses, Southern Grass Mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-0854 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-0854-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-0854-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-0854-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Grasses, Southern Grass Mix 10th of concentrate
Pollens - Grasses, Southern Grass Mix INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-0856 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-0856-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-0856-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-0856-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Trees, Acacia Acacia longifolia
Acacia longifolia INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-1006 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
ACACIA LONGIFOLIA POLLEN Acacia longifolia pollen |
|
0.05 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-1006-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-1006-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-1006-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Trees, Alder, Red Alnus rubra
Alder, Red Alnus rubra INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-1018 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
ALNUS RUBRA POLLEN ALNUS RUBRA POLLEN |
|
0.05 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-1018-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-1018-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-1018-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Trees, Alder, Red Alnus rubra
Alder, Red Alnus rubra INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-1021 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
ALNUS RUBRA POLLEN ALNUS RUBRA POLLEN |
|
0.1 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-1021-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-1021-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-1021-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Trees, Ash, White Fraxinus americana
Ash, White Fraxinus americana INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-1060 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
FRAXINUS AMERICANA POLLEN FRAXINUS AMERICANA POLLEN |
|
0.05 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-1060-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-1060-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-1060-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|
Pollens - Trees, Beech, American Fagus grandifolia
Beech, American Fagus grandifolia INJECTION, SOLUTION
Product Information
|
Product Type
|
Non-standardized allergenic label |
Item Code (Source)
|
NDC:65044-1120 |
Route of Administration
|
PERCUTANEOUS |
DEA Schedule
|
|
Active Ingredient/Active Moiety
|
Ingredient Name
|
Basis of Strength
|
Strength
|
FAGUS GRANDIFOLIA POLLEN FAGUS GRANDIFOLIA POLLEN |
|
0.05 g
|
Packaging
|
#
|
Item Code
|
Package Description
|
Marketing Start Date
|
Marketing End Date
|
1 |
NDC:65044-1120-2 |
10 in 1 VIAL |
|
|
2 |
NDC:65044-1120-3 |
30 in 1 VIAL |
|
|
3 |
NDC:65044-1120-4 |
50 in 1 VIAL |
|
|
Marketing Information
|
Marketing Category
|
Application Number or Monograph Citation
|
Marketing Start Date
|
Marketing End Date
|
BLA |
BLA103888 |
1941-04-19 |
|
|